PHAXIAM Therapeutics SA (PHXM) Stock Cash Flow
NASDAQ:PHXM - Nasdaq - US29604W2070 - ADR - Currency: USD
| 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||
| Net Income | -228.00K | -53.80M | -73.30M | |||
| Depreciation Amortization | 4.62M | 5.38M | 4.99M | |||
| Change In Working Capital | -7.58M | -7.15M | 10.80M | |||
| Interest Paid | 223.00K | 374.00K | 326.00K | |||
| Taxes Paid | 3.00K | 2.00K | N/A | |||
| Other non cash items | -28.57M | -1.20M | 5.78M | |||
| OPERATING CASH FLOW | -31.76M | -56.77M | -51.72M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||
| Capital Expenditure | -85.00K | -298.00K | -1.14M | |||
| Other Investing Activity | 38.21M | -47.00K | -336.00K | |||
| INVESTING CASH FLOW | 38.13M | -345.00K | -1.48M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||
| Debt Issued/Reduced | -1.54M | 10.46M | 25.46M | |||
| Stock Issued/Repurchased | 0.00 | 34.63M | 130.00K | |||
| Other Financing Activity | -223.00K | -374.00K | -138.00K | |||
| FINANCING CASH FLOW | -1.77M | 44.71M | 25.45M | |||
| Exchange Rate Effect | 495.00K | 1.66M | -981.00K | |||
| CHANGE IN CASH | 5.09M | -10.75M | -28.73M | |||
| FREE CASH FLOW | ||||||
| Operating Cash Flow | -31.76M | -56.77M | -51.72M | |||
| Capital Expenditure | -85.00K | -298.00K | -1.14M | |||
| FREE CASH FLOW | -31.85M | -57.07M | -52.86M | |||
All data in EUR